Phenytoin application in murine muscular dystrophy: behavioral improvement with no change in the abnormal intracellular Na:K ratio in skeletal muscles.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001826:Body Fluids / Q000378:metabolism*; D007424:Intracellular Fluid / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D009045:Motor Endplate / Q000187:drug effects; D009068:Movement / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000294:innervation / Q000378:metabolism*; D009137:Muscular Dystrophy, Animal / Q000378:metabolism*; D010672:Phenytoin / Q000494:pharmacology*; D011188:Potassium / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism*
D010672:Phenytoin; D012964:Sodium; D011188:Potassium